In situ-forming hydrogels for sustained ophthalmic drug delivery
- PMID: 17719120
- DOI: 10.1016/j.jconrel.2007.07.009
In situ-forming hydrogels for sustained ophthalmic drug delivery
Retraction in
-
Retraction notice to “In situ-forming hydrogels for sustained ophthalmic drug delivery.” [COREL 122/2, 119–134].J Control Release. 2013 Apr 28;167(2):219. doi: 10.1016/j.jconrel.2013.02.018. J Control Release. 2013. PMID: 23650662 No abstract available.
Abstract
Ophthalmic drug delivery is one of the most interesting and challenging endeavors facing the pharmaceutical scientist. The conventional ocular drug delivery systems like solutions, suspensions, and ointments show drawbacks such as increased precorneal elimination, high variability in efficiency, and blurred vision respectively. In situ-forming hydrogels are liquid upon instillation and undergo phase transition in the ocular cul-de-sac to form visco-elastic gel and this provides a response to environmental changes. In the past few years, an impressive number of novel temperature, pH, and ion induced in situ-forming systems have been reported for sustain ophthalmic drug delivery. Each system has its own advantages and drawbacks. The choice of a particular hydrogel depends on its intrinsic properties and envisaged therapeutic use. This review includes various temperature, pH, and ion induced in situ-forming polymeric systems used to achieve prolonged contact time of drugs with the cornea and increase their bioavailability.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
